AI MARKET SCANNING

BEONE MEDICINES

📅 Next Catalyst: Nov 05, 2026 (🌙 Close) 🏛️ HONG KONG STOCK EXCHANGE 📁 Healthcare 🏭 Biotechnology
AVG HISTORICAL GAP +0.03%
MAX GAP RECORD +0.50%
🔒 PRO INSTITUTIONAL AI PREDICTIVE WIN RATE
94.2%
REVEAL PRO DIRECTION ⚡

SENTINEL HISTORICAL GAP VIEWER

// $6160.HK
📊 1-YEAR TIMELINE (GAPS PLOTTED) 🔮 SIMULATE SETUP 🔒
Bullish Opening Gap Bearish Opening Gap T-1 Close Baseline

CATALYSTS & GAP HISTORY

Nov 05, 2026 Earnings Release 2026-11-05 (AFTER CLOSE (16:00)) 🔮 UPCOMING 🔒
Aug 05, 2026 Earnings Release 2026-08-05 (AFTER CLOSE)
-0.35%
Apr 24, 2024 Earnings Release 2024-04-24 (AFTER CLOSE)
-0.06%
Nov 13, 2023 Earnings Release 2023-11-13 (AFTER CLOSE)
+0.50%

VOLATILITY & GAP BIAS

AVG GAP MOVE 0.3%
Bullish Gaps (0)
Bearish Gaps (0)
Neutral / Flat (3)

QUANTITATIVE LIVE RADAR BLOTTER

Algorithmic execution stream for $6160.HK

EXECUTIONS2 LOGS
STATUS🔒 ENCRYPTED
Execution Date Strategy & Setup Direction Execution Range Hold Time Net PnL
2026-10-22 🔒 PRO RADAR ••• x• $•••.•• → $•••.•• 1292m +5.18%
••••-••-•• 🔒 LOCKED ••• x• $•••.•• → $•••.•• ••m +••.••%
🔒 Real-Time Strategy Telemetry Protected

Exact execution levels, Trailing Stops, and live bot signals are reserved for PRO members.

UNLOCK LIVE RADAR ⚡

📖 Intelligence Summary

BeOne Medicines AG, an oncology company, engages in discovering and developing various treatments for cancer patients in the United States, China, Europe, and internationally. The company's commercial stage products include BRUKINSA, a small molecule inhibitor of Bruton's Tyrosine Kinase (BTK) for the treatment of various blood cancers; TEVIMBRA, an anti-PD-1…

NEXT UPCOMING PREDICTIVE SIGNAL
STRONG BUY / TARGET +35%
🔓 REVEAL AI SIGNAL & TARGETS ↗